Intraventricular Administration of Cefepime for the Treatment of Meningitis due to Pseudomonas aeruginosa

Documenti analoghi

• Intraventricular Administration of Cefepime for the Treatment of Meningitis due to Pseudomonas aeruginosa
  di: Sameer Abdul Samad1*, et al.
  Pubblicazione: (2023-03-01)
• Development of criteria for interpretation and quality assessment of the results of susceptibility testing of Enterobacterales and Pseudomonas aeruginosa to cefepime-sulbactam
  di: Edelstein M.V., et al.
  Pubblicazione: (2024-12-01)
• Effects of sub-minimum inhibitory concentrations of gentamicin on alginate produced by clinical isolates of Pseudomonas aeruginosa
  di: Navid Saidi, et al.
  Pubblicazione: (2023-01-01)
• Activity of polymyxin B combined with cefepime-avibactam against the biofilms of polymyxin B-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae in in vitro and in vivo models
  di: Miaomei Tian, et al.
  Pubblicazione: (2024-10-01)
• Successful use of cefepime/zidebactam in deep-seated infections due to extensively drug-resistant Pseudomonas aeruginosa: A case series
  di: Pooja Shah, et al.
  Pubblicazione: (2025-09-01)